Loading clinical trials...
Loading clinical trials...
The current cohort study of 300 stable COPD patients aims to assess the following topics: * The prevalence of anxiety and depressive disorders in patients with COPD * The screening properties of Hospital Anxiety and Depression Scale in patients with COPD * The prognostic influence by anxiety or depressive symptoms and anxiety or depressive disorder. * whether characterization of 1) affective aspects of dyspnea symptoms or 2) persistent styles of thinking (worry or rumination) and metacognitions that drive these may improve the current recommendation of screening for anxiety and depression in COPD in relation to its clinical relevance on functional status and three year outcome
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
LHL-hospital Gardermoen
Jessheim, Norway
Start Date
June 15, 2018
Primary Completion Date
December 1, 2023
Completion Date
December 1, 2025
Last Updated
June 11, 2020
200
ACTUAL participants
Lead Sponsor
University Hospital, Akershus
Collaborators
NCT07115329
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07477600